Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.7B | 6.5B | 5.8B | 5.7B |
Cost of revenue | 2.2B | 2.6B | 2.4B | 2.3B |
Gross profit | 3.5B | 3.9B | 3.4B | 3.4B |
Operating expense | ||||
Research & development | 379M | 442M | 383M | 391M |
Selling general and admin | 1.9B | 2.0B | 2.1B | 1.9B |
Other operating expenses | — | — | — | — |
Operating income | 1.3B | 1.4B | 958M | 1.2B |
Non operating interest income | ||||
Income | 6M | 14M | 4M | 39M |
Expense | 72M | 61M | 87M | 65M |
Other income expense | -79M | -63M | 102M | -59M |
Pretax income | 1.1B | 1.3B | 977M | 1.1B |
Tax provision | 175M | 229M | 159M | 176M |
Net income | 954M | 1.1B | 818M | 907M |
Basic EPS | 1.3 | 1.5 | 1.1 | 1.2 |
Diluted EPS | 1.3 | 1.5 | 1.1 | 1.2 |
Basic average shares | 716.3M | 722.7M | 723M | 737.6M |
Diluted average shares | 720.8M | 728.2M | 729.4M | 742.4M |
EBITDA | 1.9B | 2.0B | 1.6B | 1.8B |
Net income from continuing op. | 954M | 1.1B | 818M | 907M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |